Condition: Neurogenic Detrusor Overactivity · Sponsor: Urovant Sciences GmbH
The purpose of this study is to evaluate the safety, efficacy, and PK of Vibegron in pediatric participants with NDO who are regularly using CIC
This description comes directly from the study's public registry record.
Study Director · 833-876-8268 · clinicaltrials@us.sumitomo-pharma.com
Always discuss trial participation with your own doctor first.
| Arkansas Childrens Hospital | Little Rock, Arkansas, United States | Recruiting |
| Children's Hospital of Orange County | Orange, California, United States | Terminated |
| Children's Hospital Colorado | Aurora, Colorado, United States | Recruiting |
| Nemours Childrens Health, Jacksonville | Jacksonville, Florida, United States | Recruiting |
| Wichita Urology Group | Wichita, Kansas, United States | Recruiting |
| Childrens Hospital New Orleans | New Orleans, Louisiana, United States | Withdrawn |
| Albany Medical College | Albany, New York, United States | Recruiting |
| SUNY Upstate Medical University | Syracuse, New York, United States | Recruiting |
| Duke University Medical Center | Durham, North Carolina, United States | Terminated |
| University of Oklahoma | Oklahoma City, Oklahoma, United States | Recruiting |
| Oregon Health & Science University | Portland, Oregon, United States | Withdrawn |
| Universitair Ziekenhuis Antwerpen | Edegem, Antwerpen, Belgium | Withdrawn |
+ 26 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05491525